Overview Multicenter Uveitis Steroid Treatment (MUST) Trial Status: Completed Trial end date: 2010-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the effectiveness of standardized systemic therapy versus fluocinolone acetonide implant therapy for the treatment of severe cases of non-infectious intermediate uveitis, posterior uveitis, or panuveitis. Phase: Phase 4 Details Lead Sponsor: JHSPH Center for Clinical TrialsCollaborator: National Eye Institute (NEI)Treatments: Alkylating AgentsAzathioprineChlorambucilCyclophosphamideCyclosporineCyclosporinsDaclizumabFluocinolone AcetonideImmunosuppressive AgentsInfliximabMethotrexateMycophenolate mofetilMycophenolic AcidTacrolimus